Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
5-valent influenza + Hib combined vaccine
- Development stage
- Preclinical
- Lead developer
- Shandong Kunli Biopharmaceutical
- Modality
- Vaccines & Immunotherapeutics
- Administration
- Intramuscular
01
Overview
5-valent influenza + Hib combined vaccine is a preclinical-stage combination vaccine being developed by Shandong Kunli Biopharmaceutical. The vaccine is designed to provide simultaneous protection against two distinct infectious disease categories: influenza and *Haemophilus influenzae* type b (Hib) infections. The formulation combines a pentavalent influenza antigen component with a Hib conjugate vaccine component, aiming to broaden immunological coverage and reduce the number of required injections. The vaccine targets five specific strains of the influenza virus alongside *Haemophilus influenzae* type b.
- Other names
- 5价流感疫苗 + Hib结合疫苗5价流感+HIB联合菌苗5-valent Influenza + HIB Combined Vaccine
02
Targets
HA0 (Influenza B virus hemagglutinin)PRNP (Cellular Prion Protein)Neuraminidase
Beyond the preview
Go deeper on 5-valent influenza + Hib combined vaccine.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on 5-valent influenza + Hib combined vaccine.